🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with numerous of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.

Some professionals said the popularity for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.

Service Response and Content Removal

Based on TikTok, the service has removed violative content and prohibited related keywords and search suggestions. The company stated it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Digital Trading Activities

Research also discovered groups with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, filled with photos of slimming results, glowing testimonials and detailed guides for preparing or injecting at residence.

After moments of entering one community, a seller posted contact information, where the majority of transactions occur. The seller provided an guidebook and promised delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, health issues or previous experience.

Product Information and Costs

Within these communities, posts display dark colored parcels with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service said it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Even if the science behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has already seen patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to potentially serious medical dangers”.